NW
← Newsroom
Life ScienceDecember 5, 2016 · 2 min read

Single Molecule Detection of a Cancer Biomarker

@ Polytechnic Institute of New York University

Using a nano-enhanced version of a device capable of detecting the smallest viruses in solution, researchers at the Polytechnic Institute of New York University (NYU-Poly) have demonstrated that they can detect a single cancer marker protein without the use of fluorescent labels. Stephen Arnold and his collaborators describe their new device in the journal Nano Letters.

In 2012, Dr. Arnold and his team were able to detect in solution the smallest known RNA virus, MS2, with a mass of 6 attograms. Now, the NYU-Poly team has detected: a human cancer marker protein called thyroglobulin, with a mass of just 1 attogram, and the bovine form of a common plasma protein, serum albumin, with a far smaller mass of 0.11 attogram. An attogram is 10-18 grams, or a millionth of a millionth of a millionth of a gram.

This latest milestone builds on a technique pioneered by Arnold and collaborators from NYU-Poly and Fordham University. In 2012, the researchers set a sizing record by treating a novel biosensor with plasmonic gold nano-receptors, enhancing the electric field of the sensor and allowing even the smallest shifts in resonant frequency to be detected. Their plan was to design a medical diagnostic device capable of identifying a single virus particle in a point-of-care setting, without the use of special assay preparations.

To the surprise of the researchers, examination of their nanoreceptor under a transmission electron microscope revealed that its gold shell surface was covered with random bumps roughly the size of a protein. Computer mapping and simulations created by Stephen Holler, once a student in the Arnold laboratory and now at Fordham University, showed that these irregularities generate their own highly reactive local sensitivity field extending out several nanometers, amplifying the capabilities of the sensor far beyond original predictions.

Dr. Arnold and his collaborators named the novel method of label-free detection “whispering gallery-mode biosensing” because light waves in the system reminded him of the way that voices bounce around the whispering gallery under the dome of St. Paul’s Cathedral in London. A laser sends light through a glass fiber to a detector. When a microsphere is placed against the fiber, certain wavelengths of light detour into the sphere and bounce around inside, creating a dip in the light that the detector receives. When a molecule such as a cancer marker clings to a gold nanoshell attached to the microsphere, the microsphere’s resonant frequency shifts by a measureable amount.

This work is detailed in a paper titled, “Label-free detection of single protein using a nanoplasmonic-photonic hybrid microcavity.” An investigator from the New York City College of Technology also participated in this study. An abstract of this paper is available at the journal’s website.

Label-Free Detection of Single Protein Using a Nanoplasmonic-Photonic Hybrid Microcavity

Venkata R. Dantham†, Stephen Holler†‡, Curtis Barbre†, David Keng†, Vasily Kolchenko§, and Stephen Arnold†*

† Microparticle Photophysics Lab, Polytechnic Institute of NYU, Brooklyn, New York 11201, United States

‡ Department of Physics, Fordham University, Bronx, New York 10458, United States

§ Department of Biological Sciences, NYC College of Technology, Brooklyn, New York 11201, United States

Nano Lett., 2013, 13 (7), pp 3347–3351

DOI: 10.1021/nl401633y

Polytechnic Institute of New York University

#Bionano #Plasmonics #GoldNanoparticles #Cancer #Photonics

More news

Life ScienceOct 19 · 2 min read

A molecular pendulum for efficient hydrogen production

Researchers at Ruhr University Bochum have shown how zinc inhibits [FeFe]-hydrogenases, enzymes that produce hydrogen, by binding two surface histidines near a known proton transport pathway. One histidine acts as a molecular pendulum, receiving a proton at the enzyme surface and delivering it inward. Replacing it slowed hydrogen production; replacing the other left the enzyme active but zinc insensitive.

Life ScienceOct 16 · 3 min read

A new, robust, long-lasting, and safe nucleic acid therapeutic

Researchers at the Institute of Science Tokyo have developed Chol-HDO[PMO], a cholesterol-conjugated heteroduplex oligonucleotide pairing a phosphorodiamidate morpholino oligomer with complementary RNA. Delivered into cerebrospinal fluid, it silenced or modulated target genes in mice with up to 16-fold greater potency than conventional antisense designs, and the effect was long lasting. It avoided acute neurotoxicity, weight loss and immune reactions.

Life ScienceOct 16 · 5 min read

Real-time nanoscale imaging shows that how much of a protein is present does not necessarily reveal how accessible it is to antibodies

High-speed atomic force microscopy has revealed that the amount of PD-L1 on cancer-derived extracellular vesicles does not indicate how accessible the protein is to antibodies. Researchers at Kanazawa University imaged individual vesicles from two breast cancer cell lines in liquid, finding that over 80 percent of high-PD-L1 vesicles held antibodies persistently, while most low-PD-L1 vesicles showed no stable binding.